Olaris CEO sits on panel, "The Evolving Role of Biomarkers and Diagnostics"

Olaris CEO, Dr. Liz O'Day, sits on a panel at the Cancer Advance Conference to discuss how biomarkers and diagnostics are changing how we treat cancer. 

April 24, 2019

Olaris CEO sits on panel, "The Evolving Role of Biomarkers and Diagnostics"